The Institute for Clinical and Economic Review flagged five drugs whose prices were raised in 2023 with no evidence to ...
El Mundo on MSN5h
Drug that protects against HIV with two 'shots' a year, discovery of the year for 'Science'Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...
A review found half of the drugs studied had price increases based on new evidence of benefits, while the other half did not.
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback